Just Announced: More Affordable Insulin Options for Medicare Beneficiaries Coming Soon
Breakthrough T1D welcomes the May 26th announcement by the Centers for Medicare & Medicaid Services about more affordable insulin options…
Enhanced Charitable Giving Incentives Explained: What it Means for Donors in 2020
What the federal economic relief package, also known as the CARES Act (Coronavirus Aid, Relief, and Economic Security) means for donors to Breakthrough…
Breakthrough T1D Spokesperson Lauren Cox #3 in WNBA draft
Lauren Cox was 7 when she was diagnosed with type 1 diabetes (T1D). She was 12 when she finally beat…
Insurance Coverage at Risk? What to do immediately.
While no one wants to think about losing their job, it is better to be prepared. This is especially true…
Special Diabetes Program Funding Extended Allowing Critical Type 1 Diabetes Research to Continue
The Federal Government has continued its commitment to support diabetes research by providing more than $75 million into the Special Diabetes Program (SDP), which…
Talking to Eli Lilly about Our Insulin Supply
Will we be OK? Our colleagues at Beyond Type One interviewed an insulin-supply expert at the Eli Lilly and Company…
Breakthrough T1D Receives Legacy Gift from the Estate of Marguerite Rosner
Generous donation furthers Breakthrough T1D mission to treat, prevent and find cures for type 1 diabetes.
New Breakthrough T1D-Funded Study finds Lifetime T1D Management Costs a Collective $813 Billion
Cost for each diagnosed American is nearly $500,000.
Insulin Affordability Matters: Advocating to Make Insulin More Affordable for All
More than 1.25 million Americans live with type 1 diabetes (T1D), and this number continues to grow. They need insulin…
FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia
On Tuesday, the type 1 diabetes (T1D) community got a helping hand in their ability to avoid severe hypoglycemia when…
